247 related articles for article (PubMed ID: 25672724)
1. [Recent progress in diagnosis and pathomechanism of inclusion body myositis].
Aoki M; Suzuki N; Kato M; Warita H
Rinsho Shinkeigaku; 2014; 54(12):1115-8. PubMed ID: 25672724
[TBL] [Abstract][Full Text] [Related]
2. [Sporadic inclusion body myositis in Japan].
Aoki M; Suzuki N
Nihon Rinsho; 2012 May; 70(5):895-906. PubMed ID: 22620019
[TBL] [Abstract][Full Text] [Related]
3. [Sporadic inclusion body myositis and amyloid].
Aoki M; Suzuki N
Brain Nerve; 2014 Jul; 66(7):739-48. PubMed ID: 24998819
[TBL] [Abstract][Full Text] [Related]
4. [Inclusion body myositis].
Suzuki N; Aoki M
Brain Nerve; 2011 Nov; 63(11):1205-15. PubMed ID: 22068473
[TBL] [Abstract][Full Text] [Related]
5. [Pathomechanism and prevalence of sporadic inclusion body myositis (sIBM)].
Suzuki N; Tateyama M; Warita H; Izumi R; Nishino I; Aoki M
Rinsho Shinkeigaku; 2011 Nov; 51(11):964-6. PubMed ID: 22277440
[TBL] [Abstract][Full Text] [Related]
6. Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis.
Tawara N; Yamashita S; Zhang X; Korogi M; Zhang Z; Doki T; Matsuo Y; Nakane S; Maeda Y; Sugie K; Suzuki N; Aoki M; Ando Y
Ann Neurol; 2017 Apr; 81(4):512-525. PubMed ID: 28318044
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features of sporadic inclusion body myositis in China.
Li K; Pu C; Huang X; Liu J; Mao Y; Lu X
Neurol Neurochir Pol; 2015; 49(4):245-50. PubMed ID: 26188941
[TBL] [Abstract][Full Text] [Related]
8. Anti-cN1A antibodies do not correlate with specific clinical, electromyographic, or pathological findings in sporadic inclusion body myositis.
Paul P; Liewluck T; Ernste FC; Mandrekar J; Milone M
Muscle Nerve; 2021 Apr; 63(4):490-496. PubMed ID: 33373040
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.
Pluk H; van Hoeve BJ; van Dooren SH; Stammen-Vogelzangs J; van der Heijden A; Schelhaas HJ; Verbeek MM; Badrising UA; Arnardottir S; Gheorghe K; Lundberg IE; Boelens WC; van Engelen BG; Pruijn GJ
Ann Neurol; 2013 Mar; 73(3):397-407. PubMed ID: 23460448
[TBL] [Abstract][Full Text] [Related]
10. Novel serology testing for sporadic inclusion body myositis: disease-specificity and diagnostic utility.
Herbert MK; Pruijn GJ
Curr Opin Rheumatol; 2015 Nov; 27(6):595-600. PubMed ID: 26285103
[TBL] [Abstract][Full Text] [Related]
11. [The etiology and pathogenesis of sporadic inclusion body myositis].
Murata KY; Ito H
Brain Nerve; 2014 Nov; 66(11):1385-94. PubMed ID: 25407074
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and classification of sporadic inclusion body myositis (sIBM).
Catalán M; Selva-O'Callaghan A; Grau JM
Autoimmun Rev; 2014; 13(4-5):363-6. PubMed ID: 24424185
[TBL] [Abstract][Full Text] [Related]
13. The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan.
Suzuki N; Mori-Yoshimura M; Yamashita S; Nakano S; Murata KY; Mori M; Inamori Y; Matsui N; Kimura E; Kusaka H; Kondo T; Ito H; Higuchi I; Hashiguchi A; Nodera H; Kaji R; Tateyama M; Izumi R; Ono H; Kato M; Warita H; Takahashi T; Nishino I; Aoki M
Orphanet J Rare Dis; 2019 Jun; 14(1):155. PubMed ID: 31242950
[TBL] [Abstract][Full Text] [Related]
14. Electromyographic findings in sporadic inclusion body myositis.
Nojszewska M; Gawel M; Kierdaszuk B; Sierdziński J; Szmidt-Sałkowska E; Seroka A; Kamińska AM; Kostera-Pruszczyk A
J Electromyogr Kinesiol; 2018 Apr; 39():114-119. PubMed ID: 29482084
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Electrophysiological Findings in Hereditary Inclusion Body Myopathy Compared With Sporadic Inclusion Body Myositis.
Kazamel M; Sorenson EJ; Milone M
J Clin Neuromuscul Dis; 2016 Jun; 17(4):190-6. PubMed ID: 27224433
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic role of anti-cN1A autoantibodies in sporadic inclusion body myositis.
Yamashita S; Tawara N; Zhang Z; Nakane S; Sugie K; Suzuki N; Nishino I; Aoki M
J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):1018-1024. PubMed ID: 37451693
[TBL] [Abstract][Full Text] [Related]
17. Challenges in diagnosis and treatment of sporadic inclusion-body myositis.
Sebastian A; Misterska-Skóra M; Sebastian M; Kręcichwost R; Haczkiewicz K
Adv Clin Exp Med; 2018 Oct; 27(10):1453-1457. PubMed ID: 30088352
[TBL] [Abstract][Full Text] [Related]
18. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.
Larman HB; Salajegheh M; Nazareno R; Lam T; Sauld J; Steen H; Kong SW; Pinkus JL; Amato AA; Elledge SJ; Greenberg SA
Ann Neurol; 2013 Mar; 73(3):408-18. PubMed ID: 23596012
[TBL] [Abstract][Full Text] [Related]
19. Myositis-related autoantibody profile and clinical characteristics stratified by anti-cytosolic 5'-nucleotidase 1A status in connective tissue diseases.
Diederichsen LP; Iversen LV; Nielsen CT; Jacobsen S; Hermansen ML; Witting N; Cortes R; Korsholm SS; Krogager ME; Friis T
Muscle Nerve; 2023 Jul; 68(1):73-80. PubMed ID: 37177880
[TBL] [Abstract][Full Text] [Related]
20. Multicenter questionnaire survey for sporadic inclusion body myositis in Japan.
Suzuki N; Mori-Yoshimura M; Yamashita S; Nakano S; Murata KY; Inamori Y; Matsui N; Kimura E; Kusaka H; Kondo T; Higuchi I; Kaji R; Tateyama M; Izumi R; Ono H; Kato M; Warita H; Takahashi T; Nishino I; Aoki M
Orphanet J Rare Dis; 2016 Nov; 11(1):146. PubMed ID: 27821140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
